Näytetään tulokset 1 - 10 / 820
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Utilization of Prognostic Biomarker Soluble Urokinase Plasminogen Activator Receptor in the Emergency Department:A Tool for Safe and More Efficient Decision-making

Vertaisarvioitu
Avoin saatavuus
DOI
10.1177/11772719221081789
Holstein, Ria M.; Mäkinen, Marja T.; Castren, Maaret K.; Kaartinen, Johanna M.
Biomarker insights2022

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40364-020-00234-z
Cuesta-Mateos, Carlo; Fuentes, Patricia; Schrader, Alexandra; Juarez-Sanchez, Raquel; Loscertales, J...
Biomarker research2020

Lectins as potential tools for cancer biomarker discovery from extracellular vesicles

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40364-023-00520-6
Islam Md Khirul, Khan Misba, Gidwani Kamlesh, Witwer W Witwer, Lamminmäki Urpo, Leivo Janne
Biomarker research2023

Reproducibility in biomarker research and clinical development:a global challenge

Vertaisarvioitu
DOI
10.2217/bmm-2017-0024
Scherer, Andreas
Biomarkers in medicine2017

Development and Validation of Biomarkers

Vertaisarvioitu
Boon, J.; Fairbrother, A.; Fossi, M.; Rand, A.; Renzoni, A.; Simmonds, M.
SPRINGER1993

Novel methodologies for biomarker discovery in atherosclerosis

Vertaisarvioitu
Avoin saatavuus
DOI
10.1093/eurheartj/ehv236
Hoefer, Imo E.; Steffens, Sabine; Ala-Korpela, Mika; Baeck, Magnus; Badimon, Lina; Bochaton-Piallat,...
European heart journal2015

In vivo turnover and biodistribution of soluble AXL: implications for biomarker development

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41598-024-66665-y
Tenstad, Olav; Christakou, Eleni; Hodneland Nilsson, Linn; Gausdal, Gro; Micklem, David; Kursula, Pe...
Scientific reports2024

Extracellular Vesicles: Prospects in Prostate Cancer Biomarker Discovery and Drug Delivery

Avoin saatavuus
Lazaro Ibanez, Elisa
Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis Helsinkiensis2017

Ecto-GPR37: a potential biomarker for Parkinson’s disease

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40035-021-00232-7
Morató, Xavier; Garcia-Esparcia, Paula; Argerich, Josep; Llorens, Franc; Zerr, Inga; Paslawski, Wojc...
Translational neurodegeneration2021

Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia

Vertaisarvioitu
DOI
10.1016/j.ajog.2014.07.052
Räsänen, Juha; Quinn, Matthew J.; Laurie, Amber; Bean, Eric; Roberts, Charles T., Jr.; Nagalla, Srin...
American journal of obstetrics and gynecology2015

Utilization of Prognostic Biomarker Soluble Urokinase Plasminogen Activator Receptor in the Emergency Department:A Tool for Safe and More Efficient Decision-making

Vertaisarvioitu
Avoin saatavuus
DOI
10.1177/11772719221081789
2022

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40364-020-00234-z
2020

Lectins as potential tools for cancer biomarker discovery from extracellular vesicles

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40364-023-00520-6
2023

Reproducibility in biomarker research and clinical development:a global challenge

Vertaisarvioitu
DOI
10.2217/bmm-2017-0024
2017

Development and Validation of Biomarkers

Vertaisarvioitu
1993

Novel methodologies for biomarker discovery in atherosclerosis

Vertaisarvioitu
Avoin saatavuus
DOI
10.1093/eurheartj/ehv236
2015

In vivo turnover and biodistribution of soluble AXL: implications for biomarker development

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41598-024-66665-y
2024

Extracellular Vesicles: Prospects in Prostate Cancer Biomarker Discovery and Drug Delivery

Avoin saatavuus
2017

Ecto-GPR37: a potential biomarker for Parkinson’s disease

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40035-021-00232-7
2021

Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia

Vertaisarvioitu
DOI
10.1016/j.ajog.2014.07.052
2015